BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Neuland Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524558
ISIN Demat
INE794A01010
Book Value (Rs)
1453.5908993
NSE Symbol
NEULANDLAB
Divident Yield %
0.2
Market Cap
(Rs In Cr.)
22,069
P/E (TTM)
60.78
EPS (TTM)
283.01
Face Value
(Rs)
10
Back
Neuland Laboratories consolidated net profit rises 664.72% in the March 2026 quarter
12-May-26   Hrs IST

Net profit of Neuland Laboratories rose 664.72% to Rs 212.67 crore in the quarter ended March 2026 as against Rs 27.81 crore during the previous quarter ended March 2025. Sales rose 136.40% to Rs 776.25 crore in the quarter ended March 2026 as against Rs 328.36 crore during the previous quarter ended March 2025.

For the full year,net profit rose 39.94% to Rs 364.00 crore in the year ended March 2026 as against Rs 260.11 crore during the previous year ended March 2025. Sales rose 36.98% to Rs 2022.99 crore in the year ended March 2026 as against Rs 1476.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales776.25328.36 136 2022.991476.84 37
OPM %39.5915.56 -28.4021.89 -
PBDT312.5856.19 456 580.72335.48 73
PBT287.4939.30 632 488.98269.93 81
NP212.6727.81 665 364.00260.11 40

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)